• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 2009

View Archived Issues

Phase II data disclosed for ABT-869 in the treatment of RCC and HCC

Read More

New atypical antipsychotic JNJ-37822681 enters phase II trial in schizophrenia

Read More

RESOLVE results: improved visual acuity in diabetic macular edema with ranibizumab

Read More

Benefit of phentermine/topiramate seen in type 2 diabetes patients in phase II trial

Read More

Pooled analysis shows saxagliptin beneficial in elderly type 2 diabetes patients

Read More

Prospective analysis supports triamcinolone acetonide in Hunner's ulcer subtype IC

Read More

Recent study supports use of alfuzosin in primary bladder neck obstruction

Read More

GPC Biotech provides update on merger with Agennix

Read More

Lpath reports phase I results for iSONEP in patients with wet AMD

Read More

Nerviano Medical Sciences reports results from phase I danusertib trial

Read More

NeuroSearch begins phase Ib ACR-325 study in Parkinson's disease dyskinesias

Read More

New compounds for the treatment of obesity claimed by University of Strathclyde

Read More

Novel TpoR agonists in early development at Shanghai Hengrui

Read More

Epigenomics initiates testing of mSEPT9 in plasma samples collected in PRESEPT study

Read More

AC Immune to utilize Bayer's florbetaben in phase I trial of AD vaccine ACI-24

Read More

AstraZeneca describes VLA-5 antagonists for the treatment of cancer

Read More

RXi Pharmaceuticals presents preclinical results from animal studies of sd-rxRNA

Read More

Plexxikon initiates dosing in phase I trial of first-in-class cancer drug PLX-3397

Read More

FDA advisory committee recommends approval of Pfizer's Selzentry in HIV

Read More

CardioPharma plans to submit NDA for CardiaPill polypill

Read More

Ipsen granted manufacturing, marketing and distribution rights to Braintree's BLI-800

Read More

MediGene completes recruitment in phase II trial of EndoTAG in breast cancer

Read More

Actelion initiates phase IIb study of ACT-128800 in multiple sclerosis

Read More

FDA issues complete response letter for Spectrum's sNDA for Fusilev

Read More

MacuCLEAR and Mystic complete phase Ib trial of MC-1101 in AMD

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe